Home Other Building Blocks N,N'-Dicyclohexylurea

N,N'-Dicyclohexylurea

CAS No.:
2387-23-7
Catalog Number:
AG0039NG
Molecular Formula:
C13H24N2O
Molecular Weight:
224.3425
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5g
98%
In Stock USA
United States
$19
- +
25g
98%
In Stock USA
United States
$57
- +
100g
98%
In Stock USA
United States
$169
- +
Product Description
Catalog Number:
AG0039NG
Chemical Name:
N,N'-Dicyclohexylurea
CAS Number:
2387-23-7
Molecular Formula:
C13H24N2O
Molecular Weight:
224.3425
MDL Number:
MFCD00003829
IUPAC Name:
1,3-dicyclohexylurea
InChI:
InChI=1S/C13H24N2O/c16-13(14-11-7-3-1-4-8-11)15-12-9-5-2-6-10-12/h11-12H,1-10H2,(H2,14,15,16)
InChI Key:
ADFXKUOMJKEIND-UHFFFAOYSA-N
SMILES:
O=C(NC1CCCCC1)NC1CCCCC1
EC Number:
219-213-7
UNII:
ZV7823VVIM
Properties
Complexity:
196  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
224.189g/mol
Formal Charge:
0
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
224.348g/mol
Monoisotopic Mass:
224.189g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
41.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3  
Literature
Title Journal
Development of Ecom₅₀ and retention index models for nontargeted metabolomics: identification of 1,3-dicyclohexylurea in human serum by HPLC/mass spectrometry. Journal of chemical information and modeling 20120525
(E)-N-Butyl-3-(3,4-dihy-droxy-phen-yl)acryl-amide hemihydrate. Acta crystallographica. Section E, Structure reports online 20120301
Thermal degradation of amorphous glibenclamide. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20120101
Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase. Bioorganic & medicinal chemistry letters 20120101
2,5-Dioxopyrrolidin-1-yl 3-(furan-2-yl)acrylate. Acta crystallographica. Section E, Structure reports online 20111101
(R)-2-Phen-oxy-1-(4-phenyl-2-sulfan-ylidene-1,3-oxazolidin-3-yl)ethanone. Acta crystallographica. Section E, Structure reports online 20111001
Oleic acid induces smooth muscle foam cell formation and enhances atherosclerotic lesion development via CD36. Lipids in health and disease 20110101
Investigation of utilization of nanosuspension formulation to enhance exposure of 1,3-dicyclohexylurea in rats: Preparation for PK/PD study via subcutaneous route of nanosuspension drug delivery. Nanoscale research letters 20110101
In Vitro and In Vivo Study of Poly(ethylene glycol) Conjugated Ibuprofen to Extend the Duration of Action. Scientia pharmaceutica 20110101
Process optimization for the preparation of oligomycin-loaded folate-conjugated chitosan nanoparticles as a tumor-targeted drug delivery system using a two-level factorial design method. International journal of nanomedicine 20110101
The solid state structure and reactivity of NbCl(5) x (N,N'-dicyclohexylurea) in solution: evidence for co-ordinated urea dehydration to the relevant carbodiimide. Dalton transactions (Cambridge, England : 2003) 20100814
Hypericins as potential leads for new therapeutics. International journal of molecular sciences 20100101
Synthesis, characterization, and biological evaluation of poly(L-γ-glutamyl-glutamine)- paclitaxel nanoconjugate. International journal of nanomedicine 20100101
Targeting the OB-Folds of Replication Protein A with Small Molecules. Journal of nucleic acids 20100101
Spacer/Linker based synthesis and biological evaluation of mutual prodrugs as antiinflammatory agents. Indian journal of pharmaceutical sciences 20100101
2-(2-Chloro-3-quinol-yl)-3-phenyl-thia-zolidin-4-one. Acta crystallographica. Section E, Structure reports online 20091101
4-Methyl-3-(2-phenoxy-acet-yl)-5-phenyl-1,3,4-oxadiazinan-2-one. Acta crystallographica. Section E, Structure reports online 20090701
In vitro biologic activities of the antimicrobials triclocarban, its analogs, and triclosan in bioassay screens: receptor-based bioassay screens. Environmental health perspectives 20080901
Second-generation difluorinated cyclooctynes for copper-free click chemistry. Journal of the American Chemical Society 20080827
Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells. The Journal of pharmacology and experimental therapeutics 20080701
Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats. Basic & clinical pharmacology & toxicology 20080501
Orally bioavailable potent soluble epoxide hydrolase inhibitors. Journal of medicinal chemistry 20070809
Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis. Arthritis research & therapy 20070101
Novel peptide sequence ('IQ-tag') with high affinity for NIR fluorochromes allows protein and cell specific labeling for in vivo imaging. PloS one 20070101
14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha. American journal of physiology. Heart and circulatory physiology 20060101
Structure-activity relationships of dinucleotides: Potent and selective agonists of P2Y receptors. Purinergic signalling 20050601
Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels. American journal of physiology. Heart and circulatory physiology 20041201
Role of EETs in regulation of endothelial permeability in rat lung. American journal of physiology. Lung cellular and molecular physiology 20040201
Investigation of the active constituents of Portulaca oleraceae L. (Portulacaceae) growing in Jordan. Pakistan journal of pharmaceutical sciences 20040101
Impurity profile study of repaglinide. Journal of pharmaceutical and biomedical analysis 20030714
Rapid determination of soluble epoxide hydrolase inhibitors in rat hepatic microsomes by high-performance liquid chromatography with electrospray tandem mass spectrometry. Analytical biochemistry 20011215
Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition. The Journal of biological chemistry 20010504
Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circulation research 20001124
Properties